TickerFund Data
← All funds
IA Healthcare

Janus Henderson Global Life Sciences Equity Fund

Managed by Janus Henderson InvestorsPart of Janus Henderson Global Funds
Latest factsheet
Jul 2026
Fund size
£72.3m
Yearly charge
0.91%
Manager fee
0.75%
Income yield
Holdings
Launched
14 Sept 2023

By understanding the science and business of health care, our experienced team invests in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

Daniel Lyons, Ph.D., CFA (Portfolio Manager) · Andy Acker, CFA (Portfolio Manager)

Cumulative performance

PeriodFundSector averageBenchmarkvs sector
1M-1.99%-1.03%+0.09%
YTD+7.27%+4.40%+3.63%
1Y+34.78%+23.39%+19.90%
Since launch+10.36%+5.61%+4.99%

Top holdings · top 10: 42.54%

#HoldingWeight
1Eli Lilly9.25%
2Johnson & Johnson7.39%
3AbbVie4.69%
4UnitedHealth Group4.64%
5AstraZeneca3.67%
6Novartis2.80%
7Thermo Fisher Scientific2.69%
8Revolution Medicines2.68%
9Argenx2.44%
10Roche2.29%

Portfolio breakdown

Sector
Biotechnology35.29%
Pharmaceuticals33.08%
Devices and Medical Technology19.40%
Health Care Services11.48%
Geography
United States82.38%
Switzerland5.09%
United Kingdom3.67%
Belgium2.96%
France2.16%
Denmark1.55%
Israel1.16%
Japan0.29%
Market cap
Over $500B16.64%
$100B to $500B40.65%
$50B to $100B7.52%
$25B to $50B7.59%
$10B to $25B8.51%
$5B to $10B13.64%
$1B to $5B4.04%
$250M to $1B0.68%

Share classes

ClassISINSEDOLTypeHedgedManager feeYearly chargeMinimum
I AccGB00BPXXDL25BPXXDL2acc0.75%0.91%£3.0m
GB00BPXXDK18

Source factsheets

MonthPublished by the managerRead on
Jul 2026View original factsheet ↗23 Aug 2026
FCA reference 1002512 · Check this fund on the FCA register ↗
Figures are read from the manager’s own published factsheet and may lag the market. Past performance is not a guide to future returns, and your capital is at risk. This is information, not advice.